Kumaka Industries informs about appointment of independent additional director

21 Jul 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Kumaka Industries has informed that the Board of Directors of the Company has appointed Nitil Kamble (DIN: 09225346) as an Additional Director (Non-Executive Independent Director) on the Board of the Company with effect from 21st July, 2021, subject to the approval of Shareholders in the next Annual General Meeting. Further, as per the requirement of the Circular No. List/Comp/14/2018-19 dated 20th June, 2018 issued by BSE on the subject of enforcement of SEBI Orders regarding appointment of Directors by listed companies. The company has affirmed that the Director being appointed is not debarred from holding the office of director by virtue of any order of SEBI or any other such authority. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9 September, 2015 are given in the enclosed Annexure-1.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×